Acesso livre
Acesso livre

Emergências e Terapia Intensiva

Tratamento com dexametasona e tocilizumabe reduz consideravelmente os níveis de proteína C reativa e procalcitonina, dificultando a detecção de infecções bacterianas secundárias em pacientes com COVID-19.

6 Ago, 2021 | 11:52h

Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients – Critical Care

Imagem clínica | Mucormicose após COVID-19 em paciente com diabetes.

6 Ago, 2021 | 11:51h

Mucormycosis after COVID-19 in a patient with diabetes – The Lancet

Conteúdos relacionados:

COVID-19 and mucormycosis superinfection: the perfect storm.

ECMM/ISHAM recommendations for clinical management of COVID -19 associated mucormycosis in low- and middle-income countries.

The “Black Fungus” in India: The Emerging Syndemic of COVID-19–Associated Mucormycosis – careful use of antibiotics and corticosteroids and closely monitoring blood glucose levels are some of the strategies suggested by the authors.

Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India – Uncontrolled diabetes mellitus was the most common underlying disease; improper glucocorticoid use was independently associated with the disease.

Opinion | “Doctors have been blamed for the rise in black fungus in India, but the COVID treatment guidelines could be contributing” – improper use of antibiotics and higher than usual doses of corticosteroids may be contributing to the emergence of mucormycosis and other fungal co-infections.

What is mucormycosis, the fungal infection affecting COVID patients in India?

[Preprint] The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases From 18 Countries.

Mucormycosis: The ‘black fungus’ maiming Covid patients in India

Global Guideline for the Diagnosis and Management of Mucormycosis

Diretriz prática ESPEN | Nutrição clínica em cirurgia – “Jejum pré-operatório a partir da meia-noite é desnecessário na maioria dos pacientes. Pacientes que serão submetidos a cirurgia e não apresentam risco específico de aspiração podem ingerir líquidos claros até 2 horas antes da anestesia. Alimentos sólidos podem ser ingeridos até 6 horas antes da anestesia.”

6 Ago, 2021 | 11:42h

ESPEN practical guideline: Clinical nutrition in surgery – Clinical Nutrition

Revisão | Reanimação com fluidos na sepse para o hospitalista.

6 Ago, 2021 | 11:35h

A Narrative Review Rational Fluid Resuscitation in Sepsis for the Hospitalist: A Narrative Review – Mayo Clinic Proceedings

Pesquisadores afirmam que médicos devem abandonar os exames de urina de rotina em pacientes idosos com delirium.

6 Ago, 2021 | 11:27h

Researchers tell doctors to avoid routine urinary tests for older patients with delirium – Johns Hopkins University School of Medicine

Artigo original: Things We Do for No Reason™: Obtaining Urine Testing in Older Adults With Delirium Without Signs or Symptoms of Urinary Tract Infection – Journal of Hospital Medicine ($)

 

Comentário no Twitter (fio – clique para saber mais)

 

Estudo internacional, multicêntrico e observacional | Desfechos com traqueostomia percutânea em pacientes de alto risco em UTI.

6 Ago, 2021 | 11:25h

Percutaneous dilatational tracheotomy in high-risk ICU patients – Annals of Intensive Care

M-A | Efeitos da mobilização precoce no prognóstico de pacientes criticamente doentes.

6 Ago, 2021 | 11:24h

Effects of early mobilization on the prognosis of critically ill patients: A systematic review and meta-analysis – International Journal of Nursing Studies (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

 

Estudo pré-pós | Implementação de um conjunto de cuidados para o tratamento da isquemia mesentérica arterial oclusiva aguda reduziu a mortalidade.

6 Ago, 2021 | 11:22h

The implementation of a pathway and care bundle for the management of acute occlusive arterial mesenteric ischemia reduced mortality – Journal of Trauma and Acute Care Surgery

 

Comentário no Twitter

 

Estudo randomizado | Em pacientes não críticos hospitalizados com Covid-19, anticoagulação com heparina em dose terapêutica aumentou a probabilidade de sobrevivência à alta em comparação com a tromboprofilaxia usual.

5 Ago, 2021 | 12:02h

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 – New England Journal of Medicine

Editorial: Surviving Covid-19 with Heparin?

Comentários:

Full-dose blood thinners reduce the need for organ support in moderately ill COVID-19 patients, but not in critically ill patients – National Institutes of Health

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t – TCTMD

Canadian-Led International Study: Full-Dose Blood Thinners Benefit Moderately Ill COVID-19 Patients – University of Manitoba

 

Comentário no Twitter

 

Estudo randomizado | Em pacientes críticos hospitalizados com Covid-19, anticoagulação em dose terapêutica com heparina não resultou em melhores desfechos em comparação com a tromboprofilaxia farmacológica usual.

5 Ago, 2021 | 12:00h

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 – New England Journal of Medicine

Editorial: Surviving Covid-19 with Heparin?

Comentários:

Full-dose blood thinners reduce the need for organ support in moderately ill COVID-19 patients, but not in critically ill patients – National Institutes of Health

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t – TCTMD

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.